Welcome to Cleveland Clinic Online Health Chats

Get answers to your health questions and concerns. It's easy to be part of our live chat events, led by Cleveland Clinic physicians and health professionals.

Aortic Diseases and Marfan Syndrome
Monday, March 24, 2014 - 12 Noon (Eastern Time)

Sign up for this chat today.Register Now

Click Join Chat to join the chat in progress.You will be asked to login if you aren't already logged in.Join Chat

Matthew Eagleton, MD

  • Vascular Surgeon
  • Miller Family Heart and Vascular Institute

Lars Svensson, MD, PhD

  • Director of the Aorta Center
  • Director of the Marfan Syndrome and Connective Tissue Disorder Clinic

Rocio Moran, MD

  • Clinical Geneticist
  • Genomic Medicine Institute

The aortic valve and aorta work together to supply oxygen-rich blood throughout your body. The valve is responsible for making sure blood flows out of the heart to the aorta. The aorta is the main artery that blood flows through from the heart to the rest of your body. When the aorta and/or aortic valve are affected by a disease or condition, it can increase your risk for life-threatening events. It has been reported by the Centers for Disease Control and Prevention that over 43,000 patients die annually from aortic disease. This is greater than the number of people who die annually from breast cancer.

It is crucial to know and understand the latest treatment options available if you have been diagnosed with a condition related to the aortic valve or aorta. One such disease is Marfan syndrome, which is a condition that affects the connective tissue of the body and causes damage to the heart, aorta, and other parts of the body. This complex condition requires a specialized and experienced approach to care. Cleveland Clinic Heart & Vascular Institute cardiologists and surgeons have vast experience at treating the aorta and aortic valves and performing surgeries on this crucial area of the heart. Diseases affecting the entire aorta to the aortic valve are managed at Cleveland Clinic with a comprehensive, multidisciplinary approach. In addition to conventional surgical therapies, there are minimally invasive and endovascular approaches for almost every type of aortic disease.

Take this opportunity to learn more about aortic disease and have your questions answered by vascular surgeon Matthew Eagleton, MD, cardiac surgeon Lars Svensson, MD, PhD from the Cleveland Clinic Miller Family Heart & Vascular Institute and Rocio Moran, MD, clinical geneticist from the Genomic Medicine Institute.

Matthew Eagleton, MD is a vascular surgeon in the Department of Vascular Surgery of the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is board-certified in vascular and general surgery. Dr. Eagleton’s specialty interests include endovascular and open surgery for complex aortic disease including aortic aneurysms and aortic dissection, aneurysm pathogenesis, pediatric and congenital vascular disease and vessel wall matrix remodeling.

Lars Georg Svensson, MD, PhD is an attending surgeon and Director of the Aorta Center, Director of the Marfan Syndrome and Connective Tissue Disorder Clinic, and Director of Quality and Process Improvement in the Department of Thoracic and Cardiovascular Surgery at Cleveland Clinic. He is also a professor of surgery at Cleveland Clinic Lerner College of Medicine and Case Western Reserve University.

Dr. Svensson is board-certified in general, vascular, thoracic and cardiac surgery. He specializes in adult cardiac surgery; cardio-aortic and aortic surgery, including combined valve and aneurysm surgery; minimally invasive mitral and aortic valve surgery; mitral and aortic valve repair operations (including bicuspid valve repairs and modified David Reimplantation operation), blood conservation; prevention of stroke and paralysis after aortic surgery; Marfan syndrome; peripheral vascular surgery; Percutaneous valve surgery; and the Maze procedure.

Rocio Moran, MD, is a Clinical Geneticist with the Cleveland Clinic's Genomic Medicine Institute. She is board-certified in pediatrics, medical genetics and board eligible in biochemical genetics.

One of her clinical focuses is the identification, evaluation and diagnosis of patients with and at risk for cardiovascular disorders, specifically connective tissue disorders.

She has established the first genetics program in Cleveland Clinic's Heart and Vascular Institute, an international leader in the treatment of cardiovascular disorders which includes genetic evaluations of patients with suspected heritable cardiovascular disease to provide personalized, disease-specific treatment recommendations.

This Health Chat will open on Sunday, March 23, 2014 to allow you to submit questions. We will try to answer as many questions as possible during the chat. Please create an account to attend the chat and submit your questions.